Ocrelizumab is granted EU licence for primary progressive and relapsing remitting MS
The European Commission (EC) has granted a licence for the use of ocrelizumab, also known as Ocrevus, in people with primary progressive multiple sclerosis (PPMS) and relapsing remitting multiple sclerosis (RRMS)…Read more - http://www.ms-uk.org/ocrelizumab-grante ... mitting-ms
Ocrelizumab is granted EU licence for PPMS and RRMS
Ocrelizumab is granted EU licence for PPMS and RRMS
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11589 Views
-
Last post by NHE
-
- 0 Replies
- 1152 Views
-
Last post by NHE
-
- 0 Replies
- 1703 Views
-
Last post by NHE
-
- 0 Replies
- 690 Views
-
Last post by DIM
-
- 0 Replies
- 2492 Views
-
Last post by NHE
-
- 1 Replies
- 1358 Views
-
Last post by vesta
-
- 0 Replies
- 2094 Views
-
Last post by frodo
-
- 0 Replies
- 2006 Views
-
Last post by NHE
-
- 0 Replies
- 1516 Views
-
Last post by NHE